CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Back to Top

Advertisement

Advertisement

EUROPEAN Company Directory


Occlutech International AB

La Cours gata 4, 252 31, Helsingborg, Sweden

PHONE: +46 70433 65 21

down-arrow Created with Sketch.
down-arrow Created with Sketch.

Structural Heart / Septal Occluders

View Chart
Company Name Product Name Recommended Size of Introducer (F) Recommended Diameter of Defect for Device (mm) Device Size (mm) Delivery Device Length (cm) CE Mark Indications Comments
Occlutech International AB Occlutech ASD Occluder 7–12 Occlutech Delivery Systems (device size determines delivery sheath selection) 4–40 4, 5, 6, 7.5, 9, 10.5, 12, 13.5, 15, 16.5, 18, 19.5, 21, 24, 27, 30, 33, 36, 39, 40 (waist diameter) 80 Indicated for closure of an ASD II and is deployed via a minimally invasive catheter delivery system; intended for patients with substantiated left-right-shunt and a clear indication for closure of the defect Unique proprietary braiding technology allows for the creation of a device that has no LA clamp, avoiding any protruding hub into the left atrium
Occlutech International AB Occlutech mVSD Occluder 6–11 Occlutech Delivery Systems (device size determines delivery sheath selection) 4–20 (diameter); ≤ 7 (length) 4, 6, 8, 10, 12, 14, 16, 18, 20 (waist diameter) 80 A percutaneous, transcatheter muscular ventricular septal defect closure device designed for the occlusion of hemodynamically significant muscular ventricular septal defects Design of the device allows a smooth alignment over the defect and therefore the ability to achieve complete closure; once placed, the device exerts minimal pressure on the surrounding tissue
Occlutech International AB Occlutech PDA Occluder 6–9 Occlutech Delivery Systems (device size determines delivery sheath selection) 3.5–14 (diameter); ≥ 4.25 (length) 3.5/5, 4/6, 5/7, 6/8, 8/10, 10/12, 12/15, 14/18 (device diameter at descending aorta/device diameter at pulmonary artery) 80 Percutaneously implanted through a catheter intervention technique and intended for the nonsurgical occlusion of a patent ductus arteriosus Unique proprietary braiding technology allows for the creation of a device that has no distal clamp, avoiding any protruding hub from the aortic disc
Occlutech International AB Occlutech PFO Occluder 7–11 Occlutech Delivery Systems (device size determines delivery sheath selection) 8–18 16/18, 23/25, 27/30, 31/35 (diameter LA/RA disc) 80 Consists of a nitinol-wire mesh with “shape-memory” properties; a flexible waist connects the two small discs and conforms completely on the atrial septum once deployed; two very thin patches made of PET ensure faster sealing of the defect in the atrial septum while optimizing ingrowth of tissue Unique proprietary braiding technology allows for the creation of a device that has no LA clamp, avoiding any protruding hub into the left atrium
Occlutech International AB Occlutech PLD 6–10 Occlutech Delivery Systems (device size determines delivery sheath selection) 4 X 2–18 X 10 (crescentric-like); 3–7 (round) 4, 5, 6, 7 (square devices); 4 X 2, 6 X 3, 8 X 4, 10 X 4, 12 X 5, 14 X 6, 16 X 8, 18 X 10 (rectangular devices) 80, 110 Indicated for patients with PVL-associated hemolysis, recurrent blood transfusions, or hemodynamically significant heart failure and who are deemed at high risk for surgical intervention after consultation with surgical physicians or as an alternative to surgery with less operational time and recovery period The first and only CE-Marked device for PVL closure with different shape and waist options
Occlutech International AB Occlutech PmVSD Occluder 6–7 Occlutech Delivery Systems (device size determines delivery sheath selection) 4–12 (diameter); ≤ 5 (length) 4, 6, 8, 10, 12 (waist diameter) 80 A percutaneous, transcatheter perimembraneous ventricular septal defect closure device designed for the occlusion of hemodynamically significant perimembraneous ventricular septal defects which are located in the membranous ventricular septum Unique braiding allows for postdeployment and self adjustment of the wire braid, minimizing tissue stress and pressure
Occlutech International AB Occlutech UNI Occluder for Multifenestrated ASDs 7–12 Occlutech Delivery Systems (device size determines delivery sheath selection) 8.4–19.5 17/17, 24/24, 28.5/28.5, 33/33, 40/40 (diameter LA/RA disc) 80 An implant used to close fenestrated (multifenestrated) atrial septal defects (ie, several smaller defects which a conventional Figulla Flex II ASD/Figulla Flex II PFO would not be able to completely close); closure of an atrial septal defect is indicated in the presence of clinical symptoms (dyspnoea and cardiac insufficiency) and where a significant left-right shunt exists (Qp:Qs, ≥ 1.5) Unique proprietary braiding technology, allows for the creation of a device that has no LA clamp, avoiding any protruding hub into the left atrium

Advertisement

Advertisement

Other Devices / Closure Devices

View Chart
Company Name Product Name Type Puncture Size (F) Maximum Wire Compatibility (inch) CE Mark Indications Comments
Occlutech International AB Occlutech Hubless PDA Occluder Patent ductus arteriosus closure device No puncture needed 0.038 Yes Percutaneously implanted through a catheter intervention technique and intended for the nonsurgical occlusion of patent ductus arteriosus

Structural Heart / Atrial Shunts

View Chart
Company Name Product Name Device Size/Shunt Diameter (mm) Outer Diameter (mm) LA Profile (mm) RA Profile (mm) Delivery Type Delivery System Working Length (cm) Sheath Size (F) Requires Predilation (Yes/No) Device Design/Material CE Mark Indication Comments
Occlutech International AB Occlutech Atiral Flow Regulator (AFR) Devices are available with 8- and 10-mm fenestration and 5- and 10-mm height options (4 sizes in total) 21- and 23-mm for 8- and 10-mm devices, respectively No protrusion in LA No protrusion in RA Transcatheter delivery 80 12 F and 14 F for 8- and 10-mm, respectively Yes Nitinol wire mesh consists of a flexible waist that connects two retention discs, with a central fenestration Indicated for use in patients with heart failure, irrespective of ejection fraction (for both HFrEF and HFpEF patients) –

More Categories:

Balloons Catheters Sheaths Stents Structural Heart Valves Wires Other Devices View All

Advertisement

Latest News


April 21, 2026

TECTONIC IDE Trial of Abbott’s Coronary IVL Device Completes Enrollment 

April 21, 2026

Conavi’s IVUS-OCT System for Intravascular Imaging Cleared by FDA

April 20, 2026

KingstronBio Announces First Implant of ProStyle M Transcatheter Mitral Valve System in Confirmatory Study

Most Read Articles


Advances in Wiring and Balloon Technology for Complex PCI

With Raghav Gattani, MD, and Lindsey Cilia, MD, FACC, FSCAI

For Suspected Coronary Calcium Nodules, What Is Your Step-by-Step PCI Strategy?

With Shrilla Banerjee, MD, FRCP, FESC; Jimmy L. Kerrigan, MD, FSCAI, FACC; and Aditya S. Bharadwaj, MD, FACC, FSCAI

New PCI Directions

By Louis Verreault-Julien, MD

Back to Top
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button